1165 København K
Tlf: 21 17 95 65 (man-fre kl. 9-15)
webinar — Will a patent waiver on COVID-19 vaccines and treatments, if granted, lead to increased global access?
Date & Time:
Online via Zoom, link will be sent post registration
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and Faculty of Law, University of Copenhagen
Recent months have seen intensified global calls for an intellectual property waiver of COVID-19 related vaccines, treatments and related products. The proposal for a TRIPS waiver, made initially by India and South Africa last October, received additional impetus in May when U.S announced its initial support of the waiver and the text-based negotiations at WTO TRIPS Council. In light of these developments, this webinar will adress the ongoing debates whether a waiver is the most effective and sustainable remedy in order to facilitate affordable access and promote production capacity, or if there is reason to consider other options.
This webinar is moderated by Professor Timo Minssen (Director, CeBIL). It brings together different perspectives on the matter, featuring Professor Duncan Matthews (Queen Mary Intellectual Property Research Institute, Queen Mary University, UK) and Mr. Prashant Reddy (Patent Lawyer, India).
Link to webinar will be sent post registration.